Performance Comparison of Microfluidic and Immunomagnetic Platforms for Pancreatic CTC Enrichment
November 15, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Linhaliq
Synonyms :
ciprofloxacin inhaled
Class :
Inhaled Fluoroquinolones
Brand Name :
Linhaliq
Synonyms :
ciprofloxacin inhaled
Class :
Inhaled Fluoroquinolones
Indicated for Noncystic Fibrosis Bronchiectasis:
Patients with non-CF bronchiectasis-related (NCFBE) chronic P aeruginosa lung infection await FDA clearance for this treatment.
N/AÂ
N/AÂ
may enhance the serum concentration of CYP1A2 Inhibitors
may diminish the absorption of Quinolones
may diminish the absorption of Quinolones
may diminish the absorption of Quinolones
may diminish the absorption of Quinolones
may diminish the absorption of Quinolones
may decrease the therapeutic effect of Antibiotics
may enhance the serum concentration of CYP1A2 Inhibitors
may diminish the absorption of Quinolones
may diminish the absorption of Quinolones
may diminish the absorption of Quinolones
may diminish the absorption of Quinolones
may diminish the absorption of Quinolones
may increase the QTc-prolonging effect of Ciprofloxacin
may diminish the serum concentration of Quinolones
may enhance the serum concentration of OAT1/3 Substrates
may diminish the serum concentration of Quinolones
may diminish the serum concentration of Quinolones
may diminish the serum concentration of Quinolones
may diminish the serum concentration of Quinolones
may increase the serum concentration of CYP3A4 inhibitors
may enhance the serum concentration of ciprofloxacin
may enhance the hypoglycemic effect of Quinolones
may enhance the hypoglycemic effect of Quinolones
may enhance the hypoglycemic effect of Quinolones
may enhance the hypoglycemic effect of Quinolones
may enhance the hypoglycemic effect of Quinolones
may diminish the serum concentration of ciprofloxacin
may diminish the serum concentration of ciprofloxacin
may enhance the photosensitizing effect of photosensitizing agents
may enhance the photosensitizing effect of photosensitizing agents
may increase the cardiotoxic effect of Quinolones
may increase the cardiotoxic effect of Quinolones
may increase the cardiotoxic effect of Quinolones
may increase the cardiotoxic effect of Quinolones
may increase the cardiotoxic effect of Quinolones
May increase the toxic effect of Quinolones
May increase the toxic effect of Quinolones
May increase the toxic effect of Quinolones
May increase the toxic effect of Quinolones
May increase the toxic effect of Quinolones
May increase the toxic effect of Quinolones
May increase the toxic effect of Quinolones
May increase the toxic effect of Quinolones
May increase the toxic effect of Quinolones
May increase the toxic effect of Quinolones
may diminish the therapeutic effect of antibiotics
may diminish the therapeutic effect of antibiotics
may diminish the therapeutic effect of antibiotics
Actions and Spectrum:Â
ciprofloxacin works by inhibiting the bacterial enzyme DNA gyrase, which is responsible for the supercoiling of bacterial DNA. This inhibition interferes with DNA replication, repair, and transcription, ultimately leading to the inhibition of bacterial growth and the death of susceptible bacteria.Â
ciprofloxacin inhalation has activity against many bacteria, including Gram-negative and some Gram-positive bacteria. It is particularly effective against bacteria that commonly cause respiratory tract infections in patients with cystic fibrosis, such as Pseudomonas aeruginosa.Â
Frequency definedÂ
N/AÂ
Black box warning:Â
NoneÂ
Contraindications/caution:Â
Contraindications:Â
N/AÂ
Caution:Â
N/AÂ
Pregnancy consideration: N/AÂ
Lactation: N/AÂ
Pregnancy category:Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.   Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.   Â
Category N: There is no data available for the drug under this categoryÂ
Pharmacology:Â
Mixture of liposome-encapsulated and unencapsulated ciprofloxacin formulations for inhaled slow-releaseÂ
Pharmacodynamics:Â
N/AÂ
Pharmacokinetics:Â
N/AÂ
Administration:Â
N/AÂ
Patient information leafletÂ
Generic Name: ciprofloxacin inhaledÂ
Why do we use ciprofloxacin inhaled?Â
ciprofloxacin inhaled is primarily used to treat chronic lung infections caused by Pseudomonas aeruginosa in patients with cystic fibrosis. It is specifically indicated for the following:Â
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
